Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal.
Open Access
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 44 (12) , 823-825
- https://doi.org/10.1136/ard.44.12.823
Abstract
Antibodies to cardiolipin, closely related to the 'lupus anticoagulant', are strongly implicated in the pathogenesis of thrombosis. We record six patients, all with high titres of these antibodies (greater than SD) in serum, who developed recurrent vascular occlusions six to 12 weeks after warfarin withdrawal. Five of the six had deep vein thrombosis, while the sixth suffered a myocardial infarction. To minimise the risk of 'recurrent' thrombosis it is strongly suggested that such patients remain on long-term anticoagulation, pending the reduction of high antibody levels.Keywords
This publication has 16 references indexed in Scilit:
- Recurrent Venous Thromboembolism in Patients with a Partial Deficiency of Protein SNew England Journal of Medicine, 1984
- ANTICARDIOLIPIN ANTIBODIES AND LUPUS ANTICOAGULANTThe Lancet, 1984
- WarfarinNew England Journal of Medicine, 1984
- Cerebral infarction in systemic lupus: association with anticardiolipin antibodies.1984
- ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUSThe Lancet, 1983
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.BMJ, 1983
- Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.BMJ, 1983
- Recurring thrombo-embolic accidents caused by family-related deficiency of the fibrinolysis systemAnnals of Hematology, 1980
- Incidence of Thromboembolism After Stopping Anticoagulant TherapyPublished by American Medical Association (AMA) ,1971
- The Risk of Interrupting Long-Term Anticoagulant TreatmentCirculation, 1961